Significant Ownership of Bain Capital Life Sciences Fund, L.P.

Signature - Title
/s/ Ricky Sun - Ricky Sun, Partner of Bain Capital Life Sciences Investors, LLC
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Bain Capital Life Sciences Fund, L.P..

Notify me when Bain Capital Life Sciences Fund, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Bain Capital Life Sciences Fund, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
XFOR X4 PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share 10% $7,845,813 2,436,588 Bain Capital Life Sciences Fund, L.P. 09 Sep 2025
ANNX Annexon, Inc. Common Stock, par value $0.001 per share 4.9% $7,243,715 5,249,069 BCLS I Investco, LP 31 Dec 2024
PHVS Pharvaris N.V. Ordinary Shares, Euro 0.12 par value per share 3% $46,597,344 1,867,629 Bain Capital Life Sciences Fund, L.P. 30 Sep 2025

Schedules 13D/G Reported by Bain Capital Life Sciences Fund, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.